Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants

References

• Meeting of the Strategic Advisory Group of Experts on Immunization, April 2009: conclusions and recommendations. [accessed 2023 May 17]. https://www.who.int/publications-detail-redirect/WER8423.
   Google Scholar
• Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis. 1993;168(2):282–12. doi:10.1093/infdis/168.2.282.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vacciane in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136–43. doi:10.1016/S0140-6736(13)62630-6.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014;32(Suppl 1):A110–A16. doi:10.1016/j.vaccine.2014.04.079.
   PubMed Web of Science ®Google Scholar
• Malik A, Haldar P, Ray A, Shet A, Kapuria B, Bhadana S, Santosham M, Ghosh RS, Steinglass R, Kumar R, et al. Introducing rotavirus vaccine in the universal immunization programme in India: from evidence to policy to implementation. Vaccine. 2019;37(39):5817–24. doi:10.1016/j.vaccine.2019.07.104.
   PubMed Web of Science ®Google Scholar
• Rotavac 5D WHO - Prequalification of Medical products (IVDs, medicines, vaccines and immunization devices, vector control). 2020 July 17 [accessed 2023 May 17]. https://extranet.who.int/pqweb/content/rotavac.
   Google Scholar
• Product information for vaccines and cold chain equipment. [accessed 2023 May 18]. https://www.gavi.org/our-alliance/market-shaping/product-information-vaccines-cold-chain-equipment.
   Google Scholar
• rotavirus-vaccine-profilespdf.pdf. [accessed 2023 May 18]. https://www.gavi.org/sites/default/files/document/rotavirus-vaccine-profilespdf.pdf.
   Google Scholar
• Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine - PubMed. [accessed 2023 May 17]. https://pubmed.ncbi.nlm.nih.gov/1650128/.
   Google Scholar
• Ward RL, Bernstein DI, Smith VE, Sander DS, Shaw A, Eiden JJ, Heaton P, Offit PA, Clark HF. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. J Infect Dis. 2004;189(12):2290–3. doi:10.1086/421248.
   PubMed Web of Science ®Google Scholar
• Ella R, Babji S, Ciarlet M, Blackwelder WC, Vadrevu KM. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants. Vaccine. 2019;37(31):4407–13. doi:10.1016/j.vaccine.2019.05.069.
   PubMed Web of Science ®Google Scholar
• Ella R, Bobba R, Muralidhar S, Babji S, Vadrevu KM, Bhan MK. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India. Hum Vaccin Immunother. 2018;14(7):1791–9. doi:10.1080/21645515.2018.1450709.
   PubMed Web of Science ®Google Scholar
• Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, Murphy TM, Music S, Niu M, Varricchio F, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22(5–6):569–74. doi:10.1016/j.vaccine.2003.09.016.
   PubMed Web of Science ®Google Scholar
• Isanaka S, Guindo O, Langendorf C, Matar Seck A, Plikaytis BD, Sayinzoga-Makombe N, McNeal MM, Meyer N, Adehossi E, Djibo A, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376(12):1121–30. doi:10.1056/NEJMoa1609462.
   PubMed Web of Science ®Google Scholar
• Rongsen-Chandola T, Strand TA, Goyal N, Flem E, Rathore SS, Arya A, Winje BA, Lazarus R, Shanmugasundaram E, Babji S, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine. 2014;32(Suppl1):A134–139. doi:10.1016/j.vaccine.2014.04.078.
   PubMedGoogle Scholar
• Chandola TR, Taneja S, Goyal N, Antony K, Bhatia K, More D, Bhandari N, Cho I, Mohan K, Prasad S, et al. ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: a randomized placebo controlled trial. Heliyon. 2017;3(5):e00302. doi:10.1016/j.heliyon.2017.e00302.
   PubMed Web of Science ®Google Scholar
• Lawrence J, He S, Martin J, Schödel F, Ciarlet M, Murray AV. Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects. Hum Vaccin Immunother. 2014;10(8):2247–54. doi:10.4161/hv.29107.
   PubMed Web of Science ®Google Scholar
• Narang A, Bose A, Pandit AN, Dutta P, Kang G, Bhattacharya SK, Datta S, PV S, Delem A, Han HH, et al. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Hum Vaccin. 2009;5(6):414–9. doi:10.4161/hv.5.6.8176.
   PubMed Web of Science ®Google Scholar
• Armah GE, Breiman RF, Tapia MD, Dallas MJ., Neuzil KM, Binka FN, Sow SO, Ojwando J, Ciarlet M, Steele AD. Immunogenicity of the pentavalent rotavirus vaccine in African infants. Vaccine. 2012;30(Suppl 1):A86–A93. doi:10.1016/j.vaccine.2011.10.006.
   PubMedGoogle Scholar
• Kompithra RZ, Paul A, Manoharan D, Babji S, Sarkar R, Mathew LG, Kang G. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants. Vaccine. 2014;32(Suppl 1):A129–A133. doi:10.1016/j.vaccine.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Kawade A, Babji S, Kamath V, Raut A, Kumar CM, Kundu R, Venkatramanan P, Lalwani SK, Bavdekar A, Juvekar S, et al. Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants. Vaccine. 2019;37(19):2554–60. doi:10.1016/j.vaccine.2019.03.067.
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomised, double-blind, placebo controlled trial. Vaccine. 2012;30(1):A36–A43. doi:10.1016/j.vaccine.2011.09.120.
   PubMedGoogle Scholar
• Madhi SA, Kirsten M, Louw C, Bos P, Aspinall S, Bouckenooghe A, Neuzil KM, Steele AD. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Vaccine. 2012;30(Suppl 1):A44–A51. doi:10.1016/j.vaccine.2011.08.080.
   PubMed Web of Science ®Google Scholar
• Steele AD, Reynders J, Scholtz F, Bos P, De Beer MC, Tumbo J, Van der Merwe CF, Delem A, De Vos B. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants. J Infect Dis. 2010;202(Suppl:):S93–S100. doi:10.1086/653550.
   PubMedGoogle Scholar
• Mwenda JM, Ntoto KM, Abebe A, Enweronu‐Laryea C, Amina I, Mchomvu J, Kisakye A, Mpabalwani E, Pazvakavambwa I, Armah G, et al. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African rotavirus surveillance network. J Infect Dis. 2010;202(S1):S5–S11. doi:10.1086/653557.
   PubMedGoogle Scholar
• Ramachandran M, Das BK, Vij A, Kumar R, Bhambal SS, Kesari N, Rawat H, Bahl L, Thakur S, Woods PA, et al. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol. 1996;34(2):436–9. doi:10.1128/jcm.34.2.436-439.1996.
   PubMed Web of Science ®Google Scholar
• Tiku VR, Sharma S, Verma A, Kumar P, Raghavendhar S, Aneja S, Paul VK, Bhan MK, Ray P. Rotavirus diversity among diarrheal children in Delhi, India during 2007–2012. Vaccine. 2014;32(Suppl 1):A62–A67. doi:10.1016/j.vaccine.2014.03.005.
   PubMedGoogle Scholar
• Mishra V, Awasthi S, Nag VL, Tandon R. Genomic diversity of group a rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study. Clin Microbiol Infect. 2010;16(1):45–50. doi:10.1111/j.1469-0691.2009.02772.x.
   PubMed Web of Science ®Google Scholar
• Sharma S, Ray P, Gentsch JR, Glass RI, Kalra V, Bhan MK. Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007. J Clin Microbiol. 2008;46(4):1343–8. doi:10.1128/JCM.02358-07.
   PubMed Web of Science ®Google Scholar
• Jain V, Das BK, Bhan MK, Glass RI, Gentsch JR. Great diversity of group a rotavirus strains and high prevalence of mixed rotavirus infections in India. J Clin Microbiol. 2001;39(10):3524–9. doi:10.1128/JCM.39.10.3524-3529.2001.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Bouckenooghe A, Suryakiran PV, Smolenov I, Han HH. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants. Vaccine. 2011;29(11):2079–84. doi:10.1016/j.vaccine.2011.01.004.
   PubMed Web of Science ®Google Scholar
• Chilengi R, Mwila- Kazimbaya K, Chirwa M, Sukwa N, Chipeta C, Velu RM, Katanekwa N, Babji S, Kang G, McNeal MM, et al. Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants. Vaccine. 2021;39(27):3633–40. doi:10.1016/j.vaccine.2021.04.060.
   PubMed Web of Science ®Google Scholar
• Desselberger U. Rotaviruses. Virus Res. 2014;190:75–96. doi:10.1016/j.virusres.2014.06.016.
   PubMed Web of Science ®Google Scholar
• Angel J, Franco MA, Greenberg HB. Rotavirus immune responses and correlates of protection. Curr Opin Virol. 2012;2(4):419–25. doi:10.1016/j.coviro.2012.05.003.
   PubMed Web of Science ®Google Scholar
• ROTAVAC 5D®. WHO - Prequalification of Medical products (IVDs, medicines, vaccines and immunization devices, Vector Control). 2021 June 21 [accessed 2023 May 19]. https://extranet.who.int/pqweb/content/rotavac-5d.
   Google Scholar